To include your compound in the COVID-19 Resource Center, submit it here.

BridgeBio launches SHP-2 inhibitor play Navire

BridgeBio Pharma LLC (Palo Alto, Calif.) launched Navire Pharma Inc., a subsidiary aimed at treating genetically driven, treatment-resistant cancer,

Read the full 197 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE